CN104946709A - Method for fermenting and producing natamycin - Google Patents
Method for fermenting and producing natamycin Download PDFInfo
- Publication number
- CN104946709A CN104946709A CN201510346199.8A CN201510346199A CN104946709A CN 104946709 A CN104946709 A CN 104946709A CN 201510346199 A CN201510346199 A CN 201510346199A CN 104946709 A CN104946709 A CN 104946709A
- Authority
- CN
- China
- Prior art keywords
- natamycin
- propionate
- fermentation
- reducing sugar
- fermenting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000010298 natamycin Nutrition 0.000 title claims abstract description 45
- 239000004311 natamycin Substances 0.000 title claims abstract description 45
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 title claims abstract description 45
- 229960003255 natamycin Drugs 0.000 title claims abstract description 45
- 238000000034 method Methods 0.000 title claims abstract description 24
- 238000000855 fermentation Methods 0.000 claims abstract description 45
- 230000004151 fermentation Effects 0.000 claims abstract description 45
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims abstract description 21
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 14
- 239000008103 glucose Substances 0.000 claims description 14
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 claims description 8
- 235000010334 sodium propionate Nutrition 0.000 claims description 8
- 239000004324 sodium propionate Substances 0.000 claims description 8
- 229960003212 sodium propionate Drugs 0.000 claims description 8
- BCZXFFBUYPCTSJ-UHFFFAOYSA-L Calcium propionate Chemical compound [Ca+2].CCC([O-])=O.CCC([O-])=O BCZXFFBUYPCTSJ-UHFFFAOYSA-L 0.000 claims description 6
- 235000010331 calcium propionate Nutrition 0.000 claims description 6
- 239000004330 calcium propionate Substances 0.000 claims description 6
- 241000187747 Streptomyces Species 0.000 claims description 5
- 241000687607 Natalis Species 0.000 claims description 4
- 238000011218 seed culture Methods 0.000 claims description 3
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 239000007788 liquid Substances 0.000 description 23
- 238000004128 high performance liquid chromatography Methods 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000002609 medium Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
- 229940041514 candida albicans extract Drugs 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000012138 yeast extract Substances 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 230000008030 elimination Effects 0.000 description 5
- 238000003379 elimination reaction Methods 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000012364 cultivation method Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000003120 macrolide antibiotic agent Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical group O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 108010049926 Acetate-CoA ligase Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000493924 Streptomyces gilvosporeus Species 0.000 description 1
- 241000970906 Streptomyces natalensis Species 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 150000004291 polyenes Chemical class 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108010033058 propionate - CoA ligase Proteins 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明公开了一种发酵生产纳他霉素的方法,包括在发酵过程中同时流加还原糖和丙酸盐的步骤。由本发明方法合成纳他霉素的最高发酵单位可达8.13g/L。本发明具有纳他霉素生产周期短,发酵成本低的优势,有利于大规模产业化的优势。
The invention discloses a method for fermenting and producing natamycin, which comprises the step of simultaneously feeding reducing sugar and propionate during the fermentation process. The highest fermentation unit of natamycin synthesized by the method of the invention can reach 8.13g/L. The invention has the advantages of short natamycin production cycle and low fermentation cost, and is beneficial to large-scale industrialization.
Description
技术领域 technical field
本发明涉及以纳塔尔链霉菌(Streptomyces natalensis)发酵生产纳他霉素的工艺方法,确切的说是一种发酵生产纳他霉素的方法。 The invention relates to a process for fermenting and producing natamycin with Streptomyces natalensis , specifically a method for fermenting and producing natamycin.
背景技术 Background technique
纳他霉素是一种多烯类大环内酯抗生素,主要由恰塔努加链霉菌(Streptomyces chmanovgensis)、褐黄孢链霉菌 (Streptomyces gilvosporeus)和纳塔尔链霉菌(Streptoyces natalensis)等发酵产生。它是一种高效、广谱、安全的新型生物防腐剂和医用抗菌剂,可以专一的抑制霉菌及真菌,但对细菌没有作用,且对哺乳动物细胞毒性低,在医药、食品、农业方面有着良好的前景。但由于纳他霉素的产量较低,它作为食品添加剂的产业化生产受到一定限制。 Natamycin is a polyene macrolide antibiotic, mainly fermented by Streptomyces chmanovgensis , Streptomyces gilvosporeus and Streptoyces natalensis produce. It is a high-efficiency, broad-spectrum, safe new biological preservative and medical antibacterial agent, which can specifically inhibit mold and fungi, but has no effect on bacteria, and has low toxicity to mammalian cells. It is widely used in medicine, food, and agriculture. Has good prospects. However, due to the low yield of natamycin, its industrial production as a food additive is limited.
丙酸盐作为纳他霉素合成的前体物质,其丙酸单元作为纳他霉素大环内酯的合成单元,有利于纳他霉素大环内酯的合成;另一方面,它也可以作为乙酰辅酶A、丙酰辅酶A合成酶的诱导物,从而促进纳他霉素的合成,提高纳他霉素的产量。 Propionate is used as a precursor substance for natamycin synthesis, and its propionic acid unit is used as a synthesis unit of natamycin macrolide, which is beneficial to the synthesis of natamycin macrolide; on the other hand, it also It can be used as an inducer of acetyl-CoA and propionyl-CoA synthetase, thereby promoting the synthesis of natamycin and increasing the output of natamycin.
目前,国内外发酵生产纳他霉素,主要是通过一次性添加或单独流加短链脂肪酸,或通过流加低级醇与还原糖混合液来提高纳他霉素产量,且发酵过程中发酵液中的还原糖浓度维持在20g/L左右。本发明提出将丙酸盐与还原糖混合液流加入发酵液中,且二者在发酵液中的浓度均不超过1g/L,此方法既为纳他霉素的产生提供了足够的碳源,又使菌体处于半饥饿状态,解除了还原糖量过大对次级代谢酶系的阻遏作用,同时也避免了丙酸的毒性对菌体造成损伤;此方法将发酵周期缩短至60-90h,降低了成本,又提高了纳他霉素的产量,有利于产业化生产。 At present, the production of natamycin by fermentation at home and abroad mainly increases the yield of natamycin by adding short-chain fatty acids at one time or separately, or by adding a mixture of lower alcohol and reducing sugar. The concentration of reducing sugar in the water is maintained at about 20g/L. The present invention proposes to add propionate and reducing sugar mixed liquid flow into the fermented liquid, and the concentration of both in the fermented liquid is not more than 1g/L, this method not only provides enough carbon source for the generation of natamycin , and make the bacteria in a semi-starved state, relieve the repression of the secondary metabolic enzyme system caused by the excessive amount of reducing sugar, and also avoid the damage to the bacteria caused by the toxicity of propionic acid; this method shortens the fermentation cycle to 60- 90h, the cost is reduced, and the output of natamycin is improved, which is beneficial to industrial production.
发明内容 Contents of the invention
本发明的目的在于提高发酵罐中纳他霉素的产量。 The purpose of the present invention is to improve the output of natamycin in the fermenter.
一种发酵生产纳他霉素的方法,该方法包括配制培养基,然后在放有培养基的发酵罐中接入纳塔尔链霉菌的种子培养物,在一定条件下进行发酵,其特征在于,在发酵过程中同时流加丙酸盐及还原糖。 A method for fermenting and producing natamycin, the method comprising preparing a culture medium, then inserting a seed culture of Streptomyces natalis into a fermenter with a culture medium, and fermenting under certain conditions, which is characterized in that , Feed propionate and reducing sugar at the same time during the fermentation process.
所述还原糖和丙酸盐的比例为5-30:3。 The ratio of reducing sugar to propionate is 5-30:3.
所述丙酸盐为丙酸钠和丙酸钙中的一种或两种。 The propionate is one or both of sodium propionate and calcium propionate.
所述还原糖为葡萄糖,所述丙酸盐为丙酸钠。 The reducing sugar is glucose, and the propionate is sodium propionate.
发酵液中还原糖浓度不超过1g/L。 The reducing sugar concentration in the fermentation broth should not exceed 1g/L.
发酵液中丙酸盐浓度不超过1g/L。 The concentration of propionate in the fermentation broth should not exceed 1g/L.
还原糖和丙酸盐从20-50h间的某个时间点开始流加,直到发酵结束。 Reducing sugar and propionate start to feed from a certain point in time between 20-50h until the end of fermentation.
所使用的发酵罐容积为5-100L。 The volume of the used fermenter is 5-100L.
本发明中所述还原糖和丙酸盐的流加比例为(5-30):3,优选25:3,当还原糖与丙酸盐的流加比例小于5:3或大于30:3时,发酵产量明显降低。 The feeding ratio of reducing sugar and propionate in the present invention is (5-30):3, preferably 25:3, when the feeding ratio of reducing sugar and propionate is less than 5:3 or greater than 30:3 , the fermentation yield was significantly reduced.
由本发明方法合成纳他霉素的最高发酵单位可达8.13g/L。 The highest fermentation unit of natamycin synthesized by the method of the invention can reach 8.13g/L.
本发明流加还原糖与丙酸盐混合液生产纳他霉素所具有的优点是: The advantages of adding reducing sugar and propionate mixed solution to produce natamycin in the present invention are:
1. 操作简便,明显提高了纳他霉素产量; 1. It is easy to operate and significantly increases the yield of natamycin;
2. 缩短了纳他霉素生产周期,降低了生产成本,有利于大规模产业化。 2. The production cycle of natamycin is shortened, the production cost is reduced, and it is beneficial to large-scale industrialization.
附图说明 Description of drawings
图1为实施例1的发酵产物纳他霉素产量曲线,在图1中,横坐标为发酵时间(h),纵坐标为发酵液中所测得的纳他霉素产量(g/L); Fig. 1 is the fermented product natamycin production curve of embodiment 1, in Fig. 1, abscissa is fermentation time (h), and ordinate is the natamycin production (g/L) that measures in fermented liquid ;
图2为实施例2的发酵产物纳他霉素产量曲线,在图2中,横坐标为发酵时间(h),纵坐标为发酵液中所测得的纳他霉素产量(g/L); Fig. 2 is the natamycin yield curve of the fermentation product of Example 2. In Fig. 2, the abscissa is the fermentation time (h), and the ordinate is the natamycin yield (g/L) measured in the fermentation broth ;
图3为实施例3的发酵产物纳他霉素产量曲线,在图3中,横坐标为发酵时间(h),纵坐标为发酵液中所测得的纳他霉素产量(g/L); Fig. 3 is the natamycin yield curve of the fermentation product of Example 3. In Fig. 3, the abscissa is the fermentation time (h), and the ordinate is the natamycin yield (g/L) measured in the fermentation broth ;
图4为实施例4的发酵产物纳他霉素产量曲线,在图4中,横坐标为发酵时间(h),纵坐标为发酵液中所测得的纳他霉素产量(g/L); Fig. 4 is the fermented product natamycin production curve of embodiment 4, and in Fig. 4, abscissa is fermentation time (h), and ordinate is the natamycin production (g/L) measured in fermented liquid ;
图5为对比例1的发酵产物纳他霉素产量曲线,在图5中,横坐标为发酵时间(h),纵坐标为发酵液中所测得的纳他霉素产量(g/L)。 Figure 5 is the natamycin yield curve of the fermentation product of Comparative Example 1. In Figure 5, the abscissa is the fermentation time (h), and the ordinate is the natamycin yield (g/L) measured in the fermentation broth .
具体实施方式 Detailed ways
下面通过实施例对本发明做详细说明。 The present invention will be described in detail below by way of examples.
实施例1 Example 1
1)摇瓶种子培养:无菌条件下,将纳塔尔链霉菌孢子涂布于琼脂斜面培养基中,置于28℃培养间里培养,再将培养好的纳塔尔链霉菌实验菌株配置成孢子悬浮液,吸取1ml此悬浮液加入种子培养基(葡萄糖10g/L,酵母粉50g/L,酵母浸膏5g/L,pH 7.2)的三角瓶中,摇瓶转速220rpm、28℃、培养60h。 1) Shake flask seed culture: under aseptic conditions, spread the spores of Streptomyces natalis on the agar slant medium, culture them in the culture room at 28°C, and then configure the cultured Streptomyces natalis experimental strains Sporulation suspension, draw 1ml of this suspension and add it to the triangular flask of seed medium (glucose 10g/L, yeast powder 50g/L, yeast extract 5g/L, pH 7.2), shake the flask at 220rpm, 28°C, and cultivate 60h.
2)5L发酵罐发酵培养:将培养好的种子液以10%的接种量接种于发酵培养基(葡萄糖20g/L,酵母浸膏5g/L,酵母粉30g/L,消前 pH 7.7)的发酵罐中,装液量为3L,搅拌速度200-700rpm,培养温度28℃、溶氧维持在30%-40%,30h开始流加葡萄糖与丙酸钠混合液直到发酵结束,混合比例为25:3,总浓度为28%,发酵液中的糖及丙酸盐浓度不超过1g/L,培养70h放罐,放罐时发酵液中纳他霉素产量通过HPLC法测定达到8.13g/L(参见图1)。 2) Fermentation culture in a 5L fermenter: Inoculate the cultured seed liquid with a 10% inoculum in the fermentation medium (glucose 20g/L, yeast extract 5g/L, yeast powder 30g/L, pH 7.7 before elimination) In the fermenter, the liquid volume is 3L, the stirring speed is 200-700rpm, the culture temperature is 28°C, and the dissolved oxygen is maintained at 30%-40%. After 30h, the mixture of glucose and sodium propionate is added until the fermentation is completed. The mixing ratio is 25 : 3, the total concentration is 28%, the sugar and propionate concentration in the fermented liquid is no more than 1g/L, cultivates 70h and puts the tank, and the natamycin output in the fermented liquid when putting the tank reaches 8.13g/L by HPLC method measurement (See Figure 1).
3)HPLC检测方法如下: 3) HPLC detection method is as follows:
取0.5ml纳他霉素发酵液,加入7ml甲醇,充分摇匀后,6000rpm离心10min,取上清液用0.45μm微孔滤膜过滤即得到待测液。 Take 0.5ml of natamycin fermentation broth, add 7ml of methanol, shake well, centrifuge at 6000rpm for 10min, take the supernatant and filter it with a 0.45μm microporous membrane to obtain the test solution.
标准品的配制:精确称取0.02g、0. 04g、0.06g、0.08g、0.1g纳他霉素标准品,分别用甲醇溶解并定容至100ml,配制成0.2g/L、0.4g/L、0.6g/L、0.8g/L、1.0g/L的纳他霉素标准溶液,并制成标准曲线,待检测样品时用。 The preparation of standard product: Accurately weigh 0.02g, 0.04g, 0.06g, 0.08g, 0.1g natamycin standard product, dissolve with methanol respectively and settle to 100ml, and prepare 0.2g/L, 0.4g/L L, 0.6g/L, 0.8g/L, 1.0g/L natamycin standard solution, and make a standard curve for use when testing samples.
HPLC条件:仪器为岛津LC-15C;流动相为甲醇:水=70:30(与发酵培养基体积比v/v);色谱柱是岛津LC-C18(5μm,4.6mm×250mm);柱温为25℃;检测波长为303nm;每次进样量为;20μl进样流速为1.0ml/min。 HPLC conditions: the instrument is Shimadzu LC-15C; the mobile phase is methanol:water=70:30 (volume ratio to fermentation medium v/v); the chromatographic column is Shimadzu LC-C18 (5μm, 4.6mm×250mm); The column temperature is 25°C; the detection wavelength is 303nm; each injection volume is 20μl; the injection flow rate is 1.0ml/min.
实施例2 Example 2
1)摇瓶种子培养方法同实施例1; 1) The shake flask seed cultivation method is the same as in Example 1;
2)5L发酵罐发酵培养:将培养好的种子液以10%的接种量接种于发酵培养基(葡萄糖20g/L,酵母浸膏5g/L,酵母粉30g/L,消前 pH 7.7)的发酵罐中,装液量为3L,搅拌速度200-700rpm,培养温度28℃、溶氧维持在30%-40%,30h开始流加葡萄糖与丙酸钙混合液直到发酵结束,混合比例为15:3,总浓度为18%,发酵液中的糖及丙酸钙浓度不超过1g/L,培养70h放罐,放罐时发酵液中纳他霉素产量通过HPLC法测定达到7.26g/L(参见图2)。 2) Fermentation culture in a 5L fermenter: Inoculate the cultured seed liquid with a 10% inoculum in the fermentation medium (glucose 20g/L, yeast extract 5g/L, yeast powder 30g/L, pH 7.7 before elimination) In the fermenter, the liquid volume is 3L, the stirring speed is 200-700rpm, the culture temperature is 28°C, and the dissolved oxygen is maintained at 30%-40%. After 30h, the mixture of glucose and calcium propionate is added until the end of fermentation. The mixing ratio is 15 : 3, the total concentration is 18%, the concentration of sugar and calcium propionate in the fermented liquid is no more than 1g/L, cultivates 70h and puts the tank, and the natamycin output in the fermented liquid reaches 7.26g/L by HPLC method measurement when putting the tank (See Figure 2).
3)HPLC检测方法同实施例1。 3) The HPLC detection method is the same as in Example 1.
实施例3 Example 3
1)摇瓶种子培养方法同实施例1; 1) The shake flask seed cultivation method is the same as in Example 1;
2)5L发酵罐发酵培养:将培养好的种子液以10%的接种量接种于发酵培养基(葡萄糖20g/L,酵母浸膏5g/L,酵母粉30g/L,消前 pH 7.7)的发酵罐中,装液量为3L,搅拌速度200-700rpm,培养温度28℃、溶氧维持在30%-40%, 20h开始流加葡萄糖与丙酸钠混合液直到发酵结束,混合比例为25:3,总浓度为28%,发酵液中的糖及丙酸钙浓度不超过1g/L,培养70h放罐,放罐时发酵液中纳他霉素产量通过HPLC法测定达6.94g/L(参见图3)。 2) Fermentation culture in a 5L fermenter: Inoculate the cultured seed liquid with a 10% inoculum in the fermentation medium (glucose 20g/L, yeast extract 5g/L, yeast powder 30g/L, pH 7.7 before elimination) In the fermenter, the liquid volume is 3L, the stirring speed is 200-700rpm, the culture temperature is 28°C, and the dissolved oxygen is maintained at 30%-40%. After 20h, the mixture of glucose and sodium propionate is added until the end of fermentation. The mixing ratio is 25 : 3, the total concentration is 28%, the sugar and calcium propionate concentration in the fermented liquid is no more than 1g/L, cultivates 70h and puts the tank, and the natamycin output in the fermented liquid when putting the tank reaches 6.94g/L by HPLC method measurement (See Figure 3).
3)HPLC检测方法同实施例1。 3) The HPLC detection method is the same as in Example 1.
实施例4 Example 4
1)摇瓶种子培养方法同实施例1; 1) The shake flask seed cultivation method is the same as in Example 1;
2)5L发酵罐发酵培养:将培养好的种子液以10%的接种量接种于发酵培养基(葡萄糖20g/L,酵母浸膏5g/L,酵母粉30g/L,消前 pH 7.7)的发酵罐中,装液量为3L,搅拌速度200-700rpm,培养温度28℃、溶氧维持在30%-40%, 50h开始流加葡萄糖与丙酸钠混合液直到发酵结束,混合比例为25:3,总浓度为28%,发酵液中的糖及丙酸钙浓度不超过1g/L,培养70h放罐,放罐时发酵液中纳他霉素产量通过HPLC法测定达5.57g/L(参见图4)。 2) Fermentation culture in a 5L fermenter: Inoculate the cultured seed liquid with a 10% inoculum in the fermentation medium (glucose 20g/L, yeast extract 5g/L, yeast powder 30g/L, pH 7.7 before elimination) In the fermenter, the liquid volume is 3L, the stirring speed is 200-700rpm, the culture temperature is 28°C, and the dissolved oxygen is maintained at 30%-40%. After 50h, the mixture of glucose and sodium propionate is added until the end of fermentation. The mixing ratio is 25 : 3, the total concentration is 28%, the sugar and calcium propionate concentration in the fermented liquid is no more than 1g/L, cultivates 70h and puts the tank, and the natamycin output reaches 5.57g/L in the fermented liquid when putting the tank by HPLC method (See Figure 4).
3)HPLC检测方法同实施例1。通过以上实施例可以看出,还原糖和丙酸盐从20-50h间的某个时间点开始流加直到发酵结束都可以得到较高的纳他霉素产量,其中30h开始流加比例为25:3的葡萄糖与丙酸钠混合液得到的纳他霉素产量最高。 3) The HPLC detection method is the same as in Example 1. As can be seen from the above examples, reducing sugar and propionate can be fed from a certain time point between 20-50h until the end of fermentation to obtain a higher natamycin yield, wherein the ratio of feeding at 30h is 25 : 3 glucose and sodium propionate mixture obtained the highest natamycin yield.
对比例1 Comparative example 1
1)摇瓶种子培养方法同实施例1; 1) The shake flask seed cultivation method is the same as in Example 1;
2)5L发酵罐发酵培养:将培养好的种子液以10%的接种量接种于发酵培养基(葡萄糖20g/L,酵母浸膏5g/L,酵母粉30g/L,消前 pH 7.7)的发酵罐中,装液量为3L,搅拌速度200-700rpm,培养温度28℃、溶氧维持在30%-40%,30h开始流加25%的葡萄糖,直到发酵结束,发酵液中的糖浓度不超过1g/L,培养70h放罐,放罐时发酵液中纳他霉素产量通过HPLC法测定达到4.68g/L(参见图5)。 2) Fermentation culture in a 5L fermenter: Inoculate the cultured seed liquid with a 10% inoculum in the fermentation medium (glucose 20g/L, yeast extract 5g/L, yeast powder 30g/L, pH 7.7 before elimination) In the fermenter, the liquid volume is 3L, the stirring speed is 200-700rpm, the culture temperature is 28°C, the dissolved oxygen is maintained at 30%-40%, and 25% glucose is added at 30 hours until the end of fermentation. No more than 1g/L, cultured for 70 hours and placed in tanks, the yield of natamycin in the fermentation broth was determined to reach 4.68g/L by HPLC (see Figure 5).
3)HPLC检测方法同实施例1。 3) The HPLC detection method is the same as in Example 1.
通过对比例和实施例可以看出,同时流加还原糖与丙酸盐混合液比单独流加还原糖的的纳他霉素产量提高74%。 As can be seen from the comparative examples and examples, the natamycin yield of adding reducing sugar and propionate mixed solution simultaneously is 74% higher than that of adding reducing sugar alone.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510346199.8A CN104946709A (en) | 2015-06-19 | 2015-06-19 | Method for fermenting and producing natamycin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510346199.8A CN104946709A (en) | 2015-06-19 | 2015-06-19 | Method for fermenting and producing natamycin |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104946709A true CN104946709A (en) | 2015-09-30 |
Family
ID=54161772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510346199.8A Pending CN104946709A (en) | 2015-06-19 | 2015-06-19 | Method for fermenting and producing natamycin |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104946709A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106755216A (en) * | 2016-11-30 | 2017-05-31 | 河南科技大学 | A kind of fermentation process for improving natamycin yield |
CN109943610A (en) * | 2019-05-06 | 2019-06-28 | 淮北师范大学 | A kind of natamycin fermentation process based on exogenous saturated fatty acid addition |
CN115323020A (en) * | 2022-07-21 | 2022-11-11 | 河北圣雪大成制药有限责任公司 | A kind of fermentation medium for producing natamycin |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101550435A (en) * | 2008-04-03 | 2009-10-07 | 上海医药工业研究院 | Method for natamycin fermentation preparation |
CN101985643A (en) * | 2010-07-13 | 2011-03-16 | 厦门大学 | Method for producing natamycin in fermentation tank by adopting base material fed-batch |
-
2015
- 2015-06-19 CN CN201510346199.8A patent/CN104946709A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101550435A (en) * | 2008-04-03 | 2009-10-07 | 上海医药工业研究院 | Method for natamycin fermentation preparation |
CN101985643A (en) * | 2010-07-13 | 2011-03-16 | 厦门大学 | Method for producing natamycin in fermentation tank by adopting base material fed-batch |
Non-Patent Citations (4)
Title |
---|
ACIDSELSAYED AHMED ELSAYED 等: "Improvement in natamycin production by Streptomyces natalensis with the addition of short-chain carboxylic acids", 《PROCESS BIOCHEMISTRY》 * |
刘宁 等: "前体对纳他霉素生物合成的影响", 《中国抗生素杂志》 * |
魏宝东 等: "纳他霉素高产菌株发酵培养基优化", 《中国酿造》 * |
魏宝东: "生物防腐剂纳他霉素高产菌株选育、发酵工艺及分离提取技术研究", 《万方全文数据库》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106755216A (en) * | 2016-11-30 | 2017-05-31 | 河南科技大学 | A kind of fermentation process for improving natamycin yield |
CN109943610A (en) * | 2019-05-06 | 2019-06-28 | 淮北师范大学 | A kind of natamycin fermentation process based on exogenous saturated fatty acid addition |
CN115323020A (en) * | 2022-07-21 | 2022-11-11 | 河北圣雪大成制药有限责任公司 | A kind of fermentation medium for producing natamycin |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103740772B (en) | A kind of method promoting camphor tree sesame liquid state fermentation biosynthesizing Android tonquinol | |
Wang et al. | Efficient production of L-sorbose from D-sorbitol by whole cell immobilization of Gluconobacter oxydans WSH-003 | |
CN102399837B (en) | Method for synthesizing acarbose through microbial fermentation | |
CN101831481A (en) | New method for preparing Iturin A and homolugues thereof | |
WO2020134688A1 (en) | Method for preparing high-purity hericium erinaceus polysaccharide by fermenting hericium erinaceus, and fermentation medium thereof | |
CN102936608B (en) | Method for producing avilamycin by fermenting | |
CN102952832B (en) | Method for producing Nemadectin through fermenting | |
CN104946709A (en) | Method for fermenting and producing natamycin | |
CN101831465B (en) | Production process for improving production intensity of propionic acid | |
CN107604026B (en) | A kind of method for improving the yield of cordycepin by liquid fermentation of Cordyceps militaris | |
CN104313079B (en) | Preparation method of monensin premix | |
CN101487029A (en) | Method and device for producing n-butyric acid by microbial catalysis | |
CN106432168B (en) | The anti-vibrios reactive compound and preparation method thereof in mangrove cusp sea lotus endogenetic fungus source | |
CN101550435B (en) | Method for natamycin fermentation preparation | |
CN108265096B (en) | Preparation of pneumocandin B by microbial fermentation0Method (2) | |
CN106755216A (en) | A kind of fermentation process for improving natamycin yield | |
CN104651427A (en) | Method for preparing doramectin | |
CN109943610B (en) | A kind of natamycin fermentation process based on exogenous saturated fatty acid addition | |
CN106591401B (en) | Fermentation promoter for increasing yield of gentamicin C1a and addition method thereof | |
CN101985643B (en) | Method for producing natamycin in fermentation tank by adopting base material fed-batch | |
CN106432169B (en) | A kind of active isocoumarin class compound of anti-vibrios and its crystal | |
CN104694614A (en) | Novel extraction process of L-tryptophan | |
CN109053601A (en) | A kind of noval chemical compound LW-1 of the separation and Extraction from Aspergillus terreus secondary metabolite | |
CN107988288A (en) | A kind of method of high density fermentation production Propionibacterium bacteriocin | |
CN103509840B (en) | A kind of method improving anidulafungin precursor compound Echinocandin B output |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150930 |
|
RJ01 | Rejection of invention patent application after publication |